• 7025 malaria professionals are enjoying the free benefits of MalariaWorld today

inflammation

Host Response and Inflammation: Neutralization of Malaria Glycosylphosphatidylinositol In Vitro by Serum IgG from Malaria-Exposed Individuals

Author(s): 
Brian de Souza J., Manohursingh R., et al
Reference: 
Infect. Immun., Sep 2010; 78: 3920 - 3929.
Contact email: 
Brian.deSouza@lshtm.ac.uk

In conclusion, we have established an in vitro assay to test the toxin-neutralizing activities of antimalarial antibodies and have shown that anti-GPI antibodies from malaria-immune individuals are able to neutralize GPI-induced macrophage activation; however, the clinical relevance of anti-GPI antibodies remains to be proven, given that malarial schizonts contain other proinflammatory moieties, in addition to GPI.

Open Access | Parasite-Derived Plasma Microparticles Contribute Significantly to Malaria Infection-Induced Inflammation through Potent Macrophage Stimulation

Author(s): 
Kevin N. Couper, Tom Barnes, Julius C. R. Hafalla, Valery Combes, Bernhard Ryffel, Thomas Secher, Georges E. Grau, Eleanor M. Riley, J. Brian de Souza
Reference: 
PLoS Pathog 6(1): e1000744
Contact email: 
kevin.couper@lshtm.ac.uk

Here we demonstrate that MPs, derived from the plasma of malaria infected mice, but not naive mice, induce potent activation of macrophages in vitro as measured by CD40 up-regulation and TNF production.

Pharmacological evidence favouring the use of Nauclea latifolia in malaria ethnopharmacy: Effects against nociception, inflammation, and pyrexia in rats and mice

Author(s): 
J. Abbah, S. Amos, B. Chindo, I. Ngazal, H.O. Vongtau, B. Adzu, T. Farida, A.A. Odutola, C. Wambebe and K.S. Gamaniel
Reference: 
Journal of Ethnopharmacology, Volume 127, Issue 1, 8 January 2010, Pages 85-90
Contact email: 
jabbah@usuhs.mil

The results suggest the presence of biologically active principles in the extract with anti-nociceptive, anti-inflammatory and anti-pyretic activities that justifies its use in malaria ethnopharmacy and subsequent development for clinical application.

Syndicate content